A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls
James McMahon, Sharon R. Lewin(The Royal Melbourne Hospital), Karen Alt(Baker Heart and Diabetes Institute), Jaclyn L. Lange(Australian Centre for HIV and Hepatitis Virology Research), Jessica O’Bryan(Monash Alfred Psychiatry Research centre), Gary F. Egan(University of Melbourne), Christian Wichmann(LMU Klinikum), Graeme O’Keefe(The University of Melbourne), Marina Caskey(Rockefeller University), Janine Roney(Monash University), Ajantha Rhodes(The University of Melbourne), Judy Chang(The University of Melbourne), Fiona E. Scott(The University of Melbourne), Jillian S. Y. Lau(The University of Melbourne), Ashanti Dantanarayana(The University of Melbourne), Charlene Mackenzie(The Royal Melbourne Hospital), Alexandra Carey(Monash University), Jennifer M. Zerbato(The University of Melbourne), Richard McIntyre(Monash University), Andrew M. Scott(Ludwig Cancer Research), Carolin Tumpach(The University of Melbourne), Michael Roche(The University of Melbourne), Nancy Guo(La Trobe University), Michelle Hagenauer(Monash University), Paul Beech(Monash University), Zhanqi Liu(The University of Melbourne), Sze-Ting Lee(The University of Melbourne), Paul S. Donnelly(The University of Melbourne), Michel C. Nussenzweig(Howard Hughes Medical Institute), Christoph E. Hagemeyer(Baker Heart and Diabetes Institute), Thomas A. Rasmussen(Aarhus University Hospital)
Cited by 21
Related Papers
Evolution of antibody immunity to SARS-CoV-2
|Nature|2021|1.8k
Engineering Multifunctional Capsules through the Assembly of Metal–Phenolic Networks
|Angewandte Chemie International Edition|2014|1.1k
Immune checkpoint blockade in infectious diseases
|Nature reviews. Immunology|2017|571
Enhanced SARS-CoV-2 neutralization by dimeric IgA
|Science Translational Medicine|2020|525